Nordwest Clinic (Krankenhaus)
Nordwest Clinic (Krankenhaus)
Germany, Frankfurt am Main
Elke Jaeger
41 years of experience
Clinic is certified :
Lutetium-177 therapy in Germany typically costs from $14,000 to $22,000 per treatment cycle. The final price depends on the specific radiopharmaceutical used and hospital stay duration. Patients save about 60% compared to the US, where costs average $45,000. Fees usually cover the medication, inpatient monitoring, and mandatory radiation safety protocols.
Bookimed Expert Insight: Germany leads Europe in nuclear medicine innovations through centers like Nordwest Clinic in Frankfurt. This hospital is recognized among the world's best by Newsweek and is TÜV certified. While university hospitals in Munich may charge more, clinics in Frankfurt offer comparable high-tech care. Choosing a specialized center with integrated research institutes ensures access to the latest radiopharmaceutical protocols.
Why choose Germany for lutetium-177 therapy?
Access advanced Lutetium-177 therapy solutions in trusted clinics .
| Germany | Turkey | Austria | |
| Lutetium-177 therapy | from $14,000 | from $8,800 | from $35,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Lutetium-177 therapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lutetium-177 therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lutetium-177 therapy journey.
Day 1
Day 2
Day 3
Day 4
Day 5
Week 1-2 Post Therapy
Week 3-4 Post Therapy
Week 5-6 Post Therapy
Please note that each patient"s case is unique and the timeline may vary.
What patients like:
What patients don't like:
As the leading global medical tourism platform, we have a huge responsibility to our clients — both patients and medical centers. All the information provided on Bookimed.com is grounded in research, foresight, and expertise and meets high interest related to the product and follows:
We form our listings of clinics and doctors with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services there.
Our experienced data scientist collects data daily, monitors and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
We collect the opinions of Bookimed clients only after getting medical experience with the clinic — so everyone on the platform can trust the facility they choose. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com, you may find choice and convenience to find the best medical solutions from top medical services providers in Germany just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Our blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics in Germany, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com, please feel free to contact us at marketing@bookimed.com.
The doctor is the Head of Oncology and Hematology at Nordwest, specializing in sarcoma treatment. Recognized as one of the top German oncologists according to Focus rating, the doctor boasts over 35 years of medical practice.
Written by Kateryna Zamkovska
Lutetium-177 therapy is a targeted radiotherapy utilizing the Lutetium-177 radioisotope to treat certain cancers effectively.
Lutetium-177 PSMA therapy is a targeted radioligand treatment for advanced, metastatic castration-resistant prostate cancer. It uses radioactive particles to find and destroy cancer cells expressing prostate-specific membrane antigen. This precision medicine effectively treats tumors that no longer respond to conventional hormonal therapies or chemotherapy.
Bookimed Expert Insight: Germany remains a global leader for this therapy due to its pioneered nuclear medicine infrastructure. While many focus on the $14,000 to $22,000 cost, the real value is in the diagnostic precision. Centers like Nordwest Clinic utilize specialized research institutes to confirm PSMA-expression before treatment begins.
Patient Consensus: Patients frequently report noticeable pain relief and lower PSA levels after cycles. Many noted that radiation safety rules temporarily impact daily routines, and dry mouth is a common practical challenge.
Lutetium-177 PSMA therapy provides superior survival outcomes for advanced metastatic prostate cancer compared to standard care. This targeted radioligand treatment extends median overall survival to 15.3 months. It achieves a 50% or greater PSA reduction in 66% of patients, significantly outperforming second-line chemotherapy options.
Bookimed Expert Insight: Germany remains a global leader for this therapy due to early adoption at centers like Nordwest Clinic. While the US average for similar targeted therapy is $45,000, German clinics offer it for $14,000 to $22,000. This price gap reflects established nuclear medicine infrastructure rather than a difference in treatment quality.
Patient Consensus: Many patients find this treatment more manageable than traditional chemotherapy despite side effects like dry mouth. They often report improved mobility and reduced bone pain even when clinical responses vary.
Lutetium-177 PSMA therapy is generally well-tolerated with mild side effects. Patients commonly experience fatigue, dry mouth, and nausea within 48 hours. Temporary drops in blood cell counts occur but are usually asymptomatic. Most symptoms are manageable with conservative care and subside between cycles.
Bookimed Expert Insight: While side effects are generally mild, German clinics like Nordwest Hospital emphasize kidney protection through strict hydration protocols. Data shows that clinical settings in Germany utilize standardized blood monitoring to ensure patient safety across multiple cycles. This proactive approach helps manage potential cumulative fatigue and ensures eligibility for subsequent treatments.
Patient Consensus: Many find this therapy significantly more tolerable than chemotherapy, allowing them to remain active. Some describe a temporary wipeout feeling or taste alterations but appreciate the painless 20-minute administration.
Patients choose Germany for Lutetium-177 therapy to access established nuclear medicine protocols and specialized cancer centers. The country offers advanced peptide receptor radionuclide therapy (PRRT) with streamlined scheduling and fewer bureaucratic delays than most healthcare systems. Specialized German clinics integrate diagnostic PET-CT imaging directly with targeted radiation treatment.
Bookimed Expert Insight: The organizational efficiency in Frankfurt and other German hubs is a decisive factor for international patients. While many countries offer Lutetium-177, German centers like Nordwest Clinic integrate five research institutes to rapidly update protocols. This allows them to manage the logistical burden of coordinating radioactive isotopes and imaging far faster than general hospitals.
Patient Consensus: Patients frequently highlight that the actual treatment day feels more routine and professional than expected. They value the clear guidance on radiation precautions and the straightforward path to starting therapy without local administrative hurdles.
International patients access Lutetium-177 PSMA therapy in Germany by submitting medical history and PSMA PET-CT scans to specialized nuclear medicine departments. The process requires confirming metastatic castration-resistant prostate cancer with high PSMA expression. Patients typically coordinate through international offices or facilitators for medical visas and treatment scheduling.
Bookimed Expert Insight: Germany ranks second globally for patient requests on our platform due to its high density of nuclear medicine centers. Clinics like Nordwest Clinic in Frankfurt manage over 61,000 patients annually. This high volume allows centers to offer specialized anticancer vaccines alongside Lutetium-177, providing more comprehensive options for late-stage cases.
Patient Consensus: Many patients found that the fastest route involves translating all pathology reports into English or German immediately. They often emphasize that managing digital imaging discs is the biggest hurdle for quick medical approval.